(Q34297808)

1 August 2017

title

Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France (English)

1 reference

medium chain acyl-CoA dehydrogenase deficiency

1 August 2017

main subject

0 references

cost-effectiveness analysis

1 reference

Françoise F Hamers

1

1 reference

1 August 2017

Catherine Rumeau-Pichon

series ordinal

2

1 reference

1 August 2017

publication date

8 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

page(s)

60

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

start time

8 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

The national Austrian newborn screening program - eight years experience with mass spectrometry. past, present, and future goals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Carnitine supplementation for inborn errors of metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Recent advances in newborn screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Cost-benefit analysis of universal tandem mass spectrometry for newborn screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Newborn screening for inborn errors of metabolism: a systematic review.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Mortality of people with mental retardation in California with and without Down syndrome, 1986-1991.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Medium chain acyl-CoA dehydrogenase deficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Four years of expanded newborn screening in Portugal with tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Projected costs, risks, and benefits of expanded newborn screening for MCADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Screening newborns for inborn errors of metabolism by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Parental tolerance of false-positive newborn screening results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464722

The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-60

Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program

21 January 2018

1 reference

12 December 2020

California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry

1 reference

12 December 2020

The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005

1 reference

12 December 2020

Neonatal screening and long-term follow-up of phenylketonuria: the French database

1 reference

12 December 2020

More on medium-chain acyl-coenzyme a dehydrogenase deficiency in a neonate

1 reference

12 December 2020

Expanded newborn screening in Europe 2007

1 reference

12 December 2020

Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany)

1 reference

12 December 2020

Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors

1 reference

12 December 2020

Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2431-12-60

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference